Vaccine Effectiveness Of The Bnt162B2 Mrna Covid-19 Vaccine Against Rt-Pcr Confirmed Sars-Cov-2 Infections
Report Finds RealWorld Effectiveness of COVID19 Vaccines for First
Vaccine Effectiveness Of The Bnt162B2 Mrna Covid-19 Vaccine Against Rt-Pcr Confirmed Sars-Cov-2 Infections. Results beyond 7 days after the. Thompson mg, burgess jl, naleway al, et al.
Report Finds RealWorld Effectiveness of COVID19 Vaccines for First
Results beyond 7 days after the. In singapore, two mrna vaccines ( Effectiveness was estimated to be 87.0% (95% ci, 81.8 to 90.7) against the b.1.1.7 variant and 72.1% (95% ci, 66.4 to 76.8) against the b.1.351 variant, findings that confirm the results reported. None of the vaccinated patients required intensive care unit admission or died. Patients were excluded based on the following conditions: Thompson mg, burgess jl, naleway al, et al. 1) receipt of only 1. Vaccine effectiveness was 87.4% (95% ci: 46.0, 97.1) for any documented infection and 91.7% (95% ci: In sensitivity analyses, vaccine effectiveness estimates using ≥21 d after the first dose and ≥14 d after the second dose were found to.
46.0, 97.1) for any documented infection and 91.7% (95% ci: Thompson mg, burgess jl, naleway al, et al. 1) receipt of only 1. Patients were excluded based on the following conditions: In model 2, we conducted a separate analysis of households comprised of only adults with the same vaccination status. In sensitivity analyses, vaccine effectiveness estimates using ≥21 d after the first dose and ≥14 d after the second dose were found to. In singapore, two mrna vaccines ( Vaccine effectiveness was 87.4% (95% ci: None of the vaccinated patients required intensive care unit admission or died. Thompson mg, burgess jl, naleway al, tyner hl, yoon sk, meece j, et al. Effectiveness was estimated to be 87.0% (95% ci, 81.8 to 90.7) against the b.1.1.7 variant and 72.1% (95% ci, 66.4 to 76.8) against the b.1.351 variant, findings that confirm the results reported.
